Aptuit, Inc. plans to invest an additional $100 million in capital projects to expand capacity, improve operating efficiency, and further align its global operations. This follows the completion of two acquisitions, SSCI and EaglePicher Pharmaceutical Services, adding physical chemistry and API development and manufacturing to Aptuit’s capabilities. “During the last year, Aptuit has experienced organic revenue growth approaching 20% and enhanced our service offering substantially, in ...